Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1.79 | (264.23) | (239.87)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 7.94 | (390.70) | (312.53)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 26.64 | (462.29) | (345.41)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Viking Therapeutics soars 120% following positiv... | 18-Sep-2018 | ShareCast |
Currency | US Dollars |
Share Price | $ 25.66 |
Change Today | $ -0.03 |
% Change | -0.12 % |
52 Week High | $78.03 |
52 Week Low | $21.28 |
Volume | 5,842 |
Shares Issued | 72.03m |
Market Cap | $1,848.23m |
RiskGrade | 326 |
Strong Buy | 7 |
Buy | 10 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 19 |
Time | Volume / Share Price |
16:00 | 310,851 @ $25.66 |
15:59 | 100 @ $25.66 |
15:59 | 600 @ $25.66 |
15:59 | 163 @ $25.66 |
15:59 | 437 @ $25.66 |
You are here: research